President Donald Trump said a US "armada" was heading toward the Gulf and that Washington was watching Iran closely, even ...
The commander of Iran's Revolutionary Guards warned Washington Thursday that the force had its "finger on the trigger" in the wake of mass protests, as US President Donald Trump said ...
AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...
Net asset value (NAV) and financial results for the twelve-month period 2025The group's NAV per share in USD decreased by -4.23% ...
After what feels like an absolute eternity since it was first announced, Xbox and Playground Games have finally pulled back the curtain on the upcoming Fable reboot - and wow, this could be an Xbox ...
I can’t tell you how many times I’ve gawked at the opening sequence to Final Fantasy VII over the years. From a three-year-old, gazing up at the intro for the first time from the carpet of my living ...
The ownership landscape of the food industry giant Kraft Heinz could be on the verge of a seismic change. A recent regulatory filing has signaled that its largest and longest-standing investor, ...
At the heart of Bionxt's clinical strategy is a novel sublingual, orally dissolving film (ODF) formulation of the drug Cladribin. Cladribin is already an approved tablet therapy for Multiple Sclerosis ...
Old Republic International Corporation today reported the following results for the fourth quarter 2025: Net income of $206.3 million, compared to $105.1 million last year.Net income excluding ...
McCormick & Company, Incorporated , a global leader in flavor, today reported financial results for the fourth quarter and fiscal year ended November 30, 2025 and provided its financial outlook for ...
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive, relentless disease FDA acti ...